Symbol="EQ"
AssetType="Common Stock"
Name="Equillium Inc"
Description="Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory or immuno-inflammatory disorders with unmet medical needs. The company is headquartered in La Jolla, California."
CIK="1746466"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2223 AVENIDA DE LA PLAYA, SUITE 105, LA JOLLA, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="29768200"
EBITDA="-28731000"
PERatio="None"
PEGRatio="None"
BookValue="0.85"
DividendPerShare="0"
DividendYield="0"
EPS="-0.78"
RevenuePerShareTTM="0.717"
ProfitMargin="-1.175"
OperatingMarginTTM="-1.171"
ReturnOnAssetsTTM="-0.247"
ReturnOnEquityTTM="-0.707"
RevenueTTM="24638000"
GrossProfitTTM="15759000"
DilutedEPSTTM="-0.78"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="4.67"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.488"
EVToRevenue="-"
EVToEBITDA="-0.121"
Beta="1.251"
num_52WeekHigh="3.2"
num_52WeekLow="0.48"
num_50DayMovingAverage="0.686"
num_200DayMovingAverage="1.09"
SharesOutstanding="34414100"
DividendDate="None"
ExDividendDate="None"
symbol="EQ"
open="0.84"
high="0.87"
low="0.82"
price="0.84"
volume="90022.00"
latest_trading_day="2023-07-17"
previous_close="0.86"
change="-0.02"
change_percent="-2.3121%"
aroon_positive_momentum_days="18"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="18"
Volume_recent_avg="144317"
Change_recent_avg="-0.01"
Delta_recent_avg="0.06"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="-1.44"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="18"
Aroon_momentum_negative="82"
image_negative_thumbnail_id_1="1149"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0182.jpeg"
image_negative_thumbnail_id_2="499"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0106.jpeg"
image_neutral_thumbnail_id_1="585"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0014.jpeg"
image_neutral_thumbnail_id_2="566"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0033.jpeg"
image_positive_thumbnail_id_1="639"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0069.jpeg"
image_positive_thumbnail_id_2="960"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0122.jpeg"
image_professor_thumbnail_id_1="1179"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
image_professor_thumbnail_id_2="1190"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
